Paul J. Tiseo
Technik-/Wissenschafts-/F&E-Leiter bei COGNITION THERAPEUTICS, INC.
Aktive Positionen von Paul J. Tiseo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
COGNITION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.10.2022 | - |
Karriereverlauf von Paul J. Tiseo
Ehemalige bekannte Positionen von Paul J. Tiseo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Ausbildung von Paul J. Tiseo
Stony Brook University | Undergraduate Degree |
Lewis Katz School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
COGNITION THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Centrexion Therapeutics Corp.
Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Paul J. Tiseo
- Erfahrung